✦ LIBER ✦

Hepatitis vaccination in patients with chronic liver disease

✍ Scribed by G. Reiss; E. B. Keeffe

Book ID: 108603530
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 175 KB
Volume: 19
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2004.01906.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination against hepatitis a in patie

Vaccination against hepatitis a in patients with chronic liver disease

✍ Irphan Gaslightwala; Edmund J. Bini 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 89 KB

Vaccination against hepatitis b in patie

Vaccination against hepatitis b in patients with chronic liver disease

✍ Gary Reiss; Emmet B. Keeffe 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 200 KB

Can hepatitis B vaccination enhance immu

Can hepatitis B vaccination enhance immune response in all patients with chronic liver disease?

✍ F. Özgenç; B. Dikici; R. V. Yagci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Susceptibility to hepatitis A in patient

Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: Missed opportunities for vaccination

✍ Michael Shim; Inessa Khaykis; James Park; Edmund J. Bini 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with underlying chronic liver disease. Although HAV vaccination is recommended for all patients with chronic hepatitis C virus (HCV) infection, little is known about adherence to these recomm